Fibril

2021 Pipeline Insights into Collagen Inhibitors - Featuring Shanghai Genomics, Matrizyme & Roche Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 15, 2021
Health, Other Health, Structural proteins, Fibers, Collagen, Pipeline, Fibril, Branches of biology

b'The "Collagen Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com\'s offering.\nThis report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Collagen inhibitors pipeline landscape.

Key Points: 
  • b'The "Collagen Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com\'s offering.\nThis report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Collagen inhibitors pipeline landscape.
  • It further highlights the inactive pipeline products in this space.\nCollagen is an essential part of the framework of the design of our various body tissues.
  • Unlike canonical inhibitors of excessive accumulation of collagen-rich deposits, inhibition of collagen fibril formation targets a specific, extracellular event.
  • phase 2 include, miRagen Therapeutics.\nCollagen inhibitors pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Kanazawa University research: Diverse amyloid structures and dynamics revealed by high-speed atomic force microscopy

Retrieved on: 
Tuesday, July 28, 2020
Branches of biology, Histopathology, Structural proteins, Biology, Peripheral membrane proteins, Amyloid, Lewy body dementia, Alpha-synuclein, Fibril, Alzheimer's disease

Although certain amyloids are known to have a biological function, amyloid formation is often associated with pathologies, including Alzheimer's and Parkinson's diseases.

Key Points: 
  • Although certain amyloids are known to have a biological function, amyloid formation is often associated with pathologies, including Alzheimer's and Parkinson's diseases.
  • The scientists specifically looked at the effect of cross-seeding ('mixing') different proteins forming aggregates, and found variations in elongation rates and the structures of the fibrils.
  • In addition, the scientists examined the influence of the pH level of the microenvironment in which fibril growth takes place.
  • David B. Teplow, and Kenjiro Ono*.Self- and Cross-Seeding on alpha-Synuclein Fibril Growth Kinetics and Structure Observed by High-Speed Atomic Force Microscopy, ACS Nano Published online 17 July 2020.

Kanazawa University research: Diverse amyloid structures and dynamics revealed by high-speed atomic force microscopy

Retrieved on: 
Tuesday, July 28, 2020
Branches of biology, Histopathology, Structural proteins, Biology, Peripheral membrane proteins, Amyloid, Lewy body dementia, Alpha-synuclein, Fibril, Alzheimer's disease

Although certain amyloids are known to have a biological function, amyloid formation is often associated with pathologies, including Alzheimer's and Parkinson's diseases.

Key Points: 
  • Although certain amyloids are known to have a biological function, amyloid formation is often associated with pathologies, including Alzheimer's and Parkinson's diseases.
  • The scientists specifically looked at the effect of cross-seeding ('mixing') different proteins forming aggregates, and found variations in elongation rates and the structures of the fibrils.
  • In addition, the scientists examined the influence of the pH level of the microenvironment in which fibril growth takes place.
  • David B. Teplow, and Kenjiro Ono*.Self- and Cross-Seeding on alpha-Synuclein Fibril Growth Kinetics and Structure Observed by High-Speed Atomic Force Microscopy, ACS Nano Published online 17 July 2020.

Seevix Material Sciences Synthetic SVX Spidersilk to Be Used in Filters to Neutralize COVID-19

Retrieved on: 
Monday, May 11, 2020
SVX, Scallion virus X, Fibril, Air filter, Water filter, Inactivation, Separation processes, Gases, Nature

JERUSALEM, May 11, 2020 /PRNewswire/ -- Seevix Material Sciences Ltd., which develops and manufactures synthetic SVX spidersilk, announced today that it plans to use its patented spidersilk technology to create disposable and safe filters with high entrapment and inactivation efficacy to neutralize COVID-19 and other coronaviruses.

Key Points: 
  • JERUSALEM, May 11, 2020 /PRNewswire/ -- Seevix Material Sciences Ltd., which develops and manufactures synthetic SVX spidersilk, announced today that it plans to use its patented spidersilk technology to create disposable and safe filters with high entrapment and inactivation efficacy to neutralize COVID-19 and other coronaviruses.
  • The binding peptide can be quickly adapted to other viruses and mutating viral strains.
  • SVX fibers with the specific peptide sequence can be incorporated in textiles used in filters, used to coat the external surface of textiles, or form part of a protective insert to entrap and neutralize viruses and microbes.
  • Seevix manufactures SVX by means of a fermenter-based, sustainable, single-step biomimicry process, inducing the self-assembly of protein building blocks into nano-fibrils.

Stora Enso Acquires Swedish Cellulose Technology Company

Retrieved on: 
Monday, October 29, 2018
Stora Enso, Business, Fibers, Pulp and paper industry, Cellulose, Biomaterial, Svetogorsk, Fibril, Economy, Chemistry

Stora Enso has increased its ownership up to 100% in the Sweden-based company Cellutech AB.

Key Points: 
  • Stora Enso has increased its ownership up to 100% in the Sweden-based company Cellutech AB.
  • The company specialises in the development of new materials and applications based on cellulose, micro-fibrillated cellulose (MFC) and other wood-based components.
  • "The acquisition of Cellutech will add a new dimension to our fibre and cellulose capabilities particularly in lightweight cellulose foams and spheres.
  • We are investing in technologies and expertise that will further broaden application development competence in Stora Enso's Biomaterials Division," says Markus Mannstrm, EVP, Stora Enso Biomaterials.